PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
Whether they have a special interest or not, GPs need to become familiar with the primary care management of drug abuse and, in particular, the main classes of drugs that are available. Cocaine is the most commonly used class A drug, overtaking the use of heroin.
- Cocaine hydrochloride powder is usually snorted but sometimes injected.
- Crack cocaine is the more volatile base form produced by heating the imported hydrochloride powder with sodium bicarbonate (baking soda) and water. It is usually smoked but sometimes injected. Processing cocaine in this way produces methylbenzoylecgonine (freebase cocaine) which crosses the blood-brain barrier faster and leads to the most serious problems.
- Cocaine is occasionally injected in combination with heroin. This is known as speedballing and carries an increased risk of overdose.
Effects of cocaine
Frequency of use can lead to different clinical effects. Three patterns of use have been identified:
- Recreational user - occasional use produces euphoria, increased alertness and feelings of self-confidence and competence.This is more pronounced when smoked or injected intravenously (IV) than when powder snorted. The 'high' is followed by a plateau and then a 'come down'.
- Binge user - frequent repeated use causes tachycardia, twitching, insomnia and anxiety. The patient may experience hallucinations or persecutory delusions that can result in dangerous aggression. Prolonged binges can result in a washed-out syndrome: lethargy and deep sleep for several hours to days with spontaneous recovery.
- Chronic high-dose dependency - can result in a perforated nasal septum, severe psychiatric and medical complications and fatalities.
One study found that cocaine users had a moderate pattern of use (in terms of number of days of use per month) compared with heroin users.
- Add notes to any clinical page and create a reflective diary
- Automatically track and log every page you have viewed
- Print and export a summary to use in your appraisal
Overall cocaine use has dropped compared to 2008/9 figures although this fall appears to be levelling out. Cannabis is the type of drug most likely to be used. Emerging trends are the use of ecstasy among the 16-24 age group and of new psychoactive substances (NPS) in the 16-59 age group. The NPS category covers a wide range of easily accessible substances - so-called 'legal highs' - some of which are not legal and some of which are not that new.
UK deaths involving cocaine increased dramatically to 247 in 2014 - up from 169 deaths in 2013. Whilst this is far lower than the 1,022 deaths recorded in 2008, there has been a steadily increasing trend since 2010. UK crime agencies believe that the increased purity of powder cocaine and the variable purity of crack cocaine have contributed to this.
Early childhood trauma appears to be a risk factor in the development of cocaine abuse.
Cocaine users may present in general practice in several ways:
- Psychiatric emergency patient, who may present with acute anxiety/paranoia.
- The person discloses abuse and requests help.
- Abuse is not disclosed but the presentation is one of a cocaine-related medical problem such as asthma, chest pains and weight loss (see separate Drug Abuse - Unusual Presentations article).
- A patient on another drug (typically heroin) discloses they are now also using cocaine.
- Unusually, a body packer or stuffer requests laxatives.
- Alcohol dependency - one study showed that heavy drinkers who also use cocaine are four times more likely to develop alcohol dependency than those who do not.
- Cocaine users sometimes present with antisocial personality disorder.
If the patient has acute anxiety/paranoia, sit them down and attempt to calm them down. A cocaine 'high' wears off rapidly and the patient should soon become stable enough for further assessment. Benzodiazepines may be required acutely if words and a tranquil environment are not sufficient. If the patient presents with physical symptoms, perform a systematic examination and exclude common acute medical complications - pulmonary oedema, heart failure, myocardial infarction, stroke, hyperthermia.
Managing an initial request for help
- History: this should include current drug and alcohol use, previous treatment, current and past medical history, psychological and mental health and forensic history. Establish why they are consulting you now and why they want to stop now.
- The social situation should be assessed, during which it should be determined whether anyone else in the household is at immediate risk (eg, children, vulnerable adults).
- Physical and mental state examination.
- Offer screening for drugs, hepatitis, HIV and sexually transmitted infections (STIs) after appropriate counselling.
(This may need to be adapted to fit local shared-care guidelines):
- Review recent drug and alcohol intake.
- Assess recent risk of blood-borne viruses (HIV and hepatitis) and check that hepatitis vaccinations are complete.
- Check any change in health - eg, weight, breathing, palpitations, chest pains.
- Check the patient's skin for burns and injecting damage and their nose for septum damage.
- Monitor weight, peak flow, pulse rate for arrhythmias and blood pressure (if high, this may reflect recent use).
- Review sexual health - eg, contraception, use of condoms, last smear test, recent STIs.
- Check whether there have been any recent mental health issues, problems or significant episodes.
The following evidence-based interventions have proved to be helpful.
- Contingency management - incentives (such as shopping vouchers) are given for drug-free periods of time (confirmed by blood testing).
- Cognitive behavioural therapy (CBT) may be helpful.
- Motivational interviewing - this basically involves helping the person to think through what changes they need to make in their lives, focusing on the need to stop/limit drug use, reduce harm and prevent relapse.
- Minnesota method - this is available through self-help groups and residential centres. It is not as effective as CBT but useful in some individuals. It is based on the 'Twelve Step' approach used in other forms of addiction such as alcoholism.
Prescribed medication (must be used in conjunction with psychological and other therapies)
- Benzodiazepines (eg, diazepam) - these can help the 'come-down' and treat insomnia. Only use less than 30 mg in these circumstances and for less than two weeks.
- Antidepressants - selective serotonin reuptake inhibitors (SSRIs) are useful only if depression is a feature and other stimulant drug use has stopped. If used with cocaine, there is a potential for the rare 'serotonin syndrome' which features autonomic, neuromotor and cognitive behavioural overstimulation.
- Disulfiram (secondary care only) - there is some evidence that it interferes with the pleasure-inducing ability of cocaine. It is useful especially where there is combined alcohol/cocaine abuse.
- Beta-blockers (eg, propranolol) are useful for anxiety, particularly during withdrawal and to reduce relapse rate but can potentiate cocaine-associated asthma.
- Dexamfetamine (secondary care only) - there is some evidence that it is useful in refractory cases and where there is combined opiate addiction.
- Methadone (secondary care) - there is some evidence of benefit, particularly in mixed cocaine/opiate abuse.
- Sublingual buprenorphine solution (secondary care) - this may be useful, especially in combination with methadone, in combined cocaine/opiate abuse.
- Research currently focuses on drugs which affect dopamine metabolism, such as methylphenidate and selegiline and a 'cocaine vaccine' which produces antibodies to the drug.
The National Institute for Health and Care Excellence (NICE) suggests methadone or buprenorphine be used as first-line in opioid detoxification.
This is usually part of a shared-care protocol and involves discussing the method of cocaine use and how to minimise harm to gums, nose, skin and veins and how to avoid infection, etc.
This is useful in some patients. Prior detoxification is not always required.
Continued psychological and social support are required to prevent relapse. Ongoing monitoring by the GP is very helpful, with referral to relapse prevention specialist services as appropriate.
Further reading & references
- Drug Misuse: Findings from the 2014/15 Crime Survey for England and Wales, July 2015; Home Office
- Guidance for working with cocaine and crack users in primary care; Royal College of General Practitioners, 2004
- Hser YI, Huang D, Brecht ML, et al; Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis. 2008;27(3):13-21.
- Deaths related to drug poisoning in England and Wales, 2014 registrations; Office for National Statistics
- Back SE, Brady KT, Waldrop AE, et al; Early life trauma and sensitivity to current life stressors in individuals with and without cocaine dependence. Am J Drug Alcohol Abuse. 2008;34(4):389-96.
- Rubio G, Manzanares J, Jimenez M, et al; Use of cocaine by heavy drinkers increases vulnerability to developing alcohol dependence: a 4-year follow-up study. J Clin Psychiatry. 2008 Apr;69(4):563-70.
- Chahua M, Sanchez-Niubo A, Torrens M, et al; Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders. Qual Life Res. 2015 Sep;24(9):2129-37. doi: 10.1007/s11136-015-0943-5. Epub 2015 Feb 15.
- Watson R; Cocaine use rises markedly among 16-29 year olds. BMJ. 2002 Oct 12;325(7368):794.
- Cocaine; Pubchem, 2005 (updated 2015)
- Drug misuse: opioid detoxification; NICE Clinical Guideline (July 2007)
- Drug misuse and dependence UK guidelines on clinical management; Dept of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive (2007)
- Research For Recovery: A Review of the Drugs Evidence Base; The Scottish Government; 2010
- Drug misuse: psychosocial interventions; NICE Clinical Guideline (July 2007)
- Shorter D, Kosten TR; Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011 Nov 3;9:119. doi: 10.1186/1741-7015-9-119.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
Dr Laurence Knott
Dr Laurence Knott
Dr John Cox